Pharmacokinetics of the New Ketolide Telithromycin (HMR 3647) Administered in Ascending Single and Multiple Doses

類似資料

• Bronchopulmonary Disposition of the Ketolide Telithromycin (HMR 3647)
  著者:: Muller-Serieys, Claudette, 等
  出版事項: (2001)
• Postantibiotic Suppression of Growth of Erythromycin A-Susceptible and -Resistant Gram-Positive Bacteria by the Ketolides Telithromycin (HMR 3647) and HMR 3004
  著者:: Munckhof, Wendy J., 等
  出版事項: (2000)
• In Vitro Pharmacodynamic Studies of Activities of Ketolides HMR 3647 (Telithromycin) and HMR 3004 against Extracellular or Intracellular Helicobacter pylori
  著者:: Gustafsson, I., 等
  出版事項: (2001)
• Ketolide agents HMR 3004 and HMR 3647 (telithromycin) inhibit the growth of Plasmodium falciparum in vitro
  著者:: Makgatho, Marema, 等
  出版事項: (2015)
• In Vitro Pharmacodynamics of the New Ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniae
  著者:: Gustafsson, I., 等
  出版事項: (2000)